Search Results 1-10 of 8494 for zerona

  1. Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management - Mayo Clinic

    The Erchonia® Zerona™ 2.0 Laser (which will be used in this study) has been approved by the FDA (K123237) as a non-invasive dermatological aesthetic ...

  2. Obesity Clinical Trials - Mayo Clinic Research

    The Erchonia® Zerona™ 2.0 Laser (which will be used in this study) has been approved by the FDA (K123237) as a non-invasive dermatological aesthetic ...

  3. Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) - Mayo Clinic

    Mayo Clinic is only participatin gin Part B, and only in the MTR regimen. Participation eligibility. Participant eligibility includes age, gender, type and ...

  4. Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma - Mayo Clinic

    Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.

  5. Overview - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

    The Sarkaria Translational Neuro-Oncology Laboratory at Mayo Clinic develops novel therapeutics for glioblastoma brain cancer and brain metastases.

  6. Niraparib + TSR042 In BRCA Mutated Breast Cancer - Mayo Clinic

    The purpose of this study is to evaluate pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA mutations. The drugs are ...

  7. Publications - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

    The Mayo Clinic Brain Tumor Patient-Derived Xenograft National Resource provides a bibliography to help researchers identify other studies that have used ...

  8. Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    Inclusion Criteria: Clinical and definitive histologic diagnosis of WM. Subjects must either have relapsed/refractory disease OR be treatment naïve and ...

  10. A Study of Lower Body Negative Pressure for Research and Development on Non-Invasive Monitoring Devices - Mayo Clinic

    About this study. The purpose of this study is to see how the body responds to different levels of lower body negative pressure, specifically how the ...